RISK OF LONG-TERM USE OF LAXATIVES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper presents the pathogenetic and clinical aspects associated with the irrational and long-term use of laxatives and discusses diagnostic and therapeutic approaches to managing patients with clinical manifestive types of laxative abuse.

Full Text

Restricted Access

About the authors

I. Mayev

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: dna-mit8@mail.ru
Correspondent Member of the Russian Academy of Medical Sciences

D. Andreev

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: dna-mit8@mail.ru

D. Dicheva

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: dna-mit8@mail.ru
Candidate of Medical Sciences

I. Gurtovenko

I.M. Sechenov First Moscow State Medical University

Email: dna-mit8@mail.ru
Candidate of Medical Sciences

References

  1. Roerig J., Steffen K., Mitchell J. et al. Laxative abuse: epidemiology, diagnosis and management // Drugs. - 2010; 70 (12): 1487-503.
  2. Гастроэнтерология. Национальное руководство (краткое изд.). Под ред. В.Т. Ивашкина, Т.Л. Лапиной / М.: ГЭОТАР-Медиа, 2011; 480 c.
  3. Маев И.В., Самсонов А.А., Дичева Д.Т. и др. Обстипационный синдром // Мед. вестн. МВД. - 2012; 59 (4): 42-5.
  4. Morales M., Hernandez D., Bustamante S. et al. Is senna laxative use associated to cathartic colon, genotoxicity, or carcinogenicity? // J. Toxicol. - 2009; 2009: 287247.
  5. Hallmann F. Toxicity of commonly used laxatives // Med. Sci. Monit. - 2000; 6 (3): 618-28.
  6. Tozzi F., Thornton L., Mitchell J. et al. Features associated with laxative abuse in individuals with eating disorders // Psychosom. Med. - 2006; 68: 470-7.
  7. Vanin J., Saylor K. Laxative abuse: a hazardous habit for weight control // J. Am. Coll. Health. - 1989; 37: 227-30.
  8. Pomeroy C., Mitchell J., Roerig J. et al. Medical complications of psychiatric illness / Washington, DC: American Psychiatric Publishing Inc., 2002; 35-74.
  9. Baker E., Sandle G. Complications of laxative abuse // Ann. Rev. Med. -1996; 47: 127-34.
  10. Marquart L., Sobal J. Weight loss beliefs, practices and support systems for high school wrestlers // J. Adolesc. Health. - 1994; 15: 410-5.
  11. Shelton J., Santa-Ana C., Thompson D. et al. Factitious diarrhea induced by stimulant laxatives: accuracy of diagnosis by a clinical reference laboratory using thin layer chromatography // Clin. Chem. - 2007; 53: 85-90.
  12. Keswani R., Sauk J., Kane S. Factitious diarrhea masquerading as refractory celiac disease // South Med. J. - 2006; 99: 293-5.
  13. Savino A., Fordtran J. Factitious disease: Clinical lessons from case studies at Baylor University Medical Center // Proc. Bayl. Univ. Med. Cent. - 2006; 19: 195-208.
  14. Phillips S. Surreptitious laxative abuse: Keep it in mind // Semin. Gastrointest. Dis. - 1999; 10: 132-7.
  15. Neims D., McNeill J., Giles T. et al. Incidence of laxative abuse in community and bulimic populations: a descriptive review // Int. J. Eat. Disord. - 1995; 17: 211-28.
  16. Steffen K., Mitchell J., Roerig J. The eating disorders medicine cabinet revisited: a clinician's guide to ipecac and laxatives // Int. J. Eat. Disord. - 2007; 40: 360-8.
  17. Creytens G. Le Lactulose dans le traitement de la constipation chronique et labus des laxatives // Ars médici. - 1980; 35: 737-57.
  18. Kokot F., Hyla-Klekot L. Drug-induced abnormalities of potassium metabolism // Pol. Arch. Med. Wewn. - 2008; 118 (7-8): 431-4.
  19. Wald A. Is chronic use of stimulant laxatives harmful to the colon? // J. Clin. Gastroenterol. - 2003; 36: 386-9.
  20. Wright L., DuVal J. Renal injury associated with laxative abuse // South Med. J. - 1987; 80: 1304-6.
  21. Vanderperren B., Rizzo M., Angenot L. et al. Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides // Ann. Pharmacother. - 2005; 39: 1353-7.
  22. Минушкин О.Н. Осложнения фармакотерапии хронического запора // РМЖ. - 2003; 5 (3): 52-5.
  23. Slugg P., Carey W. Clinical features and follow-up of surreptitious laxative users // Cleveland Clin. Q. - 1984; 51: 167-71.
  24. Urso F., Urso M., Lee C. The cathartic colon: pathological findings and radiological/pathological correlation // Radiology. - 1975; 116 (3): 557-9.
  25. Campbell W. Cathartic colon. Reversibility of roentgen changes // Dis. Colon. Rectum. - 1983; 26 (7): 445-8.
  26. Freeman H. «Melanosis» in the small and large intestine // W. J. Gastroenterol. - 2008; 14 (27): 4296-9.
  27. Kostela E., Kulju T., Collan Y. Melanosis coli, prevalence, distribution and histological features in 200 consecutive autopsies at Kuopio University Central Hospital // Dis. Colon. Rectum. - 1989; 32 (3): 235-9.
  28. Ahasan H., Khan A., Mahbub H. et al. Melanosis Coli - An Atypical Presentation // J. Med. - 2010; 11 (2): 183-5.
  29. Walker N., Bennett R., Axelsen R. Melanosis coli. A consequence of anthraquinone induced apoptosis of colonic epithelial cells // Am. J. Pathol. - 1988; 131 (3): 465-6.
  30. Müller-Lissner S. The pathophysiology, diagnosis, and treatment of constipation // Deutsch. Arztebl. Int. - 2009; 106 (25): 424-31.
  31. Harris A., Buchanan G. Melanosis coli is reversible // Colorectal. Dis. -2009; 11: 788-9.
  32. Greenfeld D., Mickley D., Quinlan D. et al. Hypokalemia in outpatients with eating disorders // Am. J. Psychiatry. - 1995; 152: 60-3.
  33. Duncan A. Screening for surreptitious laxative abuse // Ann. Clin. Biochem. -2000; 37: 1-8.
  34. Phillips S., Donaldson L., Geisler K. et al. Stool composition in factitial diarrhea: a 6-year experience with stool analysis // Ann. Intern. Med. - 1995; 123 (2): 97-100.
  35. Маев И., Дичева Д., Андреев Д. Новые возможности лечения хронического запора // Врач. - 2012; 3: 45-8.
  36. Wanitschke R., Goerg K., Loew D. Differential therapy of constipation -a review // Int. J. Clin. Pharmacol. Ther. - 2003; 41 (1): 14-21.
  37. Маев И.В., Самсонов А.А., Андреев Д.Н. Современный алгоритм ведения пациентов с синдромом хронического запора с позиций внедрения новых фармакологических препаратов // Фарматека. - 2012; 13: 37-43.
  38. Черемушкин С., Кучерявый Ю. Доказательная медицина и лечение хронического запора // Врач. - 2012; 10: 42-7.
  39. Marlett J., Kajs T., Fischer M. An unfermented gel component of psyllium seed husk promotes laxation as a lubricant in humans // Am. J. Clin. Nutr. - 2000; 72: 784-9.
  40. Mehmood M., Aziz N., Ghayur M. et al. Pharmacological basis for the medicinal use of psyllium husk (Ispaghula) in constipation and diarrhea // Dig. Dis. Sci. - 2011; 56 (5): 1460-71.
  41. Hotz, J., Plein, K. Wirkung von Plantago-Samenschalen im Vergleich zu Weizenkleie auf Stuhlfrequenz und Beschwerden beim Colonirritabile Syndrom mit Obstipation // Med. Klin. - 1994; 89: 645-51.
  42. Dettmar P., Sykes J. A multi-centre, general practice comparison of ispaghula husk with lactulose and other laxatives in the treatment of simple constipation // Curr. Med. Res. Opin. - 1998; 14 (4): 227-33.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies